These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15665846)

  • 1. CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure.
    Milone G; Tornello A; Leotta S; Poidomani M; Mercurio S; Farsaci B; Consoli C; Murgano P; Giustolisi R
    Bone Marrow Transplant; 2005 Mar; 35(5):521-2; author reply 522. PubMed ID: 15665846
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
    Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
    Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transplant versus leukemia reaction].
    Savchenko VG
    Vestn Ross Akad Med Nauk; 2004; (9):61-71. PubMed ID: 15526690
    [No Abstract]   [Full Text] [Related]  

  • 4. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies.
    Booth C; Ribeil JA; Audat F; Dal-Cortivo L; Veys PA; Thrasher AJ; Davies EG; Lefrère F; Fischer A; Cavazzana-Calvo M; Gaspar HB
    Br J Haematol; 2006 Nov; 135(4):533-7. PubMed ID: 17054675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation.
    Lemarie C; Esterni B; Calmels B; Dazey B; Lapierre V; Lecchi L; Meyer A; Rea D; Thuret I; Chambost H; Curtillet C; Chabannon C; Michel G
    Bone Marrow Transplant; 2007 Apr; 39(8):453-60. PubMed ID: 17334384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
    Jabbour E; Rondon G; Anderlini P; Giralt SA; Couriel DR; Champlin RE; Khouri IF
    Bone Marrow Transplant; 2007 Sep; 40(5):431-5. PubMed ID: 17603511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
    Lang P; Mueller I; Greil J; Bader P; Schumm M; Pfeiffer M; Hoelle W; Klingebiel T; Heinzelmann F; Belka C; Schlegel PG; Kremens B; Woessmann W; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):33-9. PubMed ID: 17884640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous Cord Blood Cells Infusion as Salvage Therapy for Engraftment Failure After Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.
    de Rojas T; Fioravantti V; Deltoro N; Andión M; González-Vicent M; Madero L
    Pediatr Blood Cancer; 2016 Aug; 63(8):1495-6. PubMed ID: 27003230
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
    Ball LM; Lankester AC; Bredius RG; Fibbe WE; van Tol MJ; Egeler RM
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S35-8. PubMed ID: 15812528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
    Aversa F; Terenzi A; Tabilio A; Falzetti F; Carotti A; Ballanti S; Felicini R; Falcinelli F; Velardi A; Ruggeri L; Aloisi T; Saab JP; Santucci A; Perruccio K; Martelli MP; Mecucci C; Reisner Y; Martelli MF
    J Clin Oncol; 2005 May; 23(15):3447-54. PubMed ID: 15753458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsoclonus myoclonus following allogeneic haematopoietic stem cell transplantation.
    Bishton MJ; Das Gupta E; Byrne JL; Russell NH
    Bone Marrow Transplant; 2005 Nov; 36(10):923. PubMed ID: 16113657
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we help patients with refractory chronic graft versus host disease- single centre experience.
    Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
    Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.